MAPT and cerebral amyloid angiopathy: Similarly, for the APP/PS1 mice in which the APP and PS1 mutant gene are drove by Prnp promoter, the female mice showed more Aβ plaque and phosphorylated tau protein burdens, more severe cerebral amyloid angiopathy, neuroinflammation, and gliosis [33].